Publications & Reports

Indications of immune protection from hepatitis C infection.

Aitken CK, Bowden S, Hellard M, Crofts N
Epidemiology and Social Research Program, Macfarlane Burnet Institute for Medical Research and Public Health, PO Box 2284, Melbourne, Victoria 3001, Australia. [email protected]


Hepatitis C affects many millions of people worldwide and is at very high prevalence among people who inject drugs.

In our study of hepatitis C virus (HCV) in the social networks of injecting drug users (IDUs), five IDUs with injecting careers of 9 years or more were HCV antibody and RNA negative.

All injected frequently with HCV RNA-positive IDUs, and two had recently injected with the syringe of an RNA-positive IDU.

Our data suggest the existence of immune protection from HCV infection.


  • Journal: Journal of Urban Health
  • Published: 01/03/2004
  • Volume: 81
  • Issue: 1
  • Pagination: 58-60